Resveratrol transcriptionally regulates miRNA-18a-5p expression ameliorating diabetic nephropathy via increasing autophagy.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Review for Medical and Pharmacological Sciences

• Publication date

  2017-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 29164562
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Caffeic Acid Attenuates Diabetic Kidney Disease via Modulation of Autophagy in a High-Fat Diet/Streptozotocin- Induced Diabetic Rat

  2017cited by this paper
• Resveratrol attenuates senescence of adipose-derived mesenchymal stem cells and restores their paracrine effects on promoting insulin secretion of INS-1 cells through Pim-1.

  2016cited by this paper
• Autophagy and mitochondrial dysfunction in adjuvant-arthritis rats treatment with resveratrol

  2016cited by this paper
• MicroRNAs in apoptosis, autophagy and necroptosis

  2015cited by this paper
• An overview of microRNAs.

  2015cited by this paper
• Autophagy induced by resveratrol suppresses α‐MSH‐induced melanogenesis

  2014cited by this paper
• Autophagy inhibition induces podocyte apoptosis by activating the pro-apoptotic pathway of endoplasmic reticulum stress.

  2014cited by this paper
• Recently emerging signaling landscape of ataxia-telangiectasia mutated (ATM) kinase.

  2014cited by this paper
• Autophagy in Kidney Health and Disease

  2014cited by this paper
• Autophagy: emerging therapeutic target for diabetic nephropathy.

  2014cited by this paper
• Direct Activation of ATM by Resveratrol under Oxidizing Conditions

  2014cited by this paper
• Autophagy in diabetic nephropathy.

  2014cited by this paper
• Autophagy and the kidney: health and disease.

  2014cited by this paper
• Resveratrol attenuates vascular endothelial inflammation by inducing autophagy through the cAMP signaling pathway

  2013cited by this paper
• Autophagy is involved in the effects of resveratrol on prevention of splenocyte apoptosis caused by oxidative stress in restrained mice.

  2013cited by this paper
• Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus.

  2013cited by this paper
• Autophagy Attenuates Diabetic Glomerular Damage through Protection of Hyperglycemia-Induced Podocyte Injury

  2013cited by this paper
• Autophagy maturation associated with CD38-mediated regulation of lysosome function in mouse glomerular podocytes

  2013cited by this paper
• Renal Protective Effects of Resveratrol

  2013cited by this paper
• Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions.

  2013cited by this paper
• Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK–SIRT1–PGC1α axis in db/db mice

  2012cited by this paper
• How many ways can a podocyte die?

  2012cited by this paper
• Dietary Restriction Ameliorates Diabetic Nephropathy through Anti-Inflammatory Effects and Regulation of the Autophagy via Restoration of Sirt1 in Diabetic Wistar Fatty (fa/fa) Rats: A Model of Type 2 Diabetes

  2011cited by this paper
• Resveratrol Improves Oxidative Stress and Protects Against Diabetic Nephropathy Through Normalization of Mn-SOD Dysfunction in AMPK/SIRT1-Independent Pathway

  2011cited by this paper
• Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice.

  2010cited by this paper
• Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy

  2010cited by this paper
• Autophagy: Snapshot of the network

  2010cited by this paper
• Resveratrol, a Polyphenolic Phytoalexin, Attenuates Diabetic Nephropathy in Rats

  2006cited by this paper
• From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy.

  2005cited by this paper
• Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

  2003cited by this paper
• Mechanism of the process formation; podocytes vs. neurons

  2002cited by this paper
• Transcriptional regulation of podocyte specification and differentiation

  2002cited by this paper
• Autophagy as a regulated pathway of cellular degradation.

  2000cited by this paper
• Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.

  1997cited by this paper

• Targeting programmed cell death pathways: emerging therapeutic strategies for diabetic kidney disease

  2025cites this paper
• MicroRNAs for Diabetes Management: From Natural Bioactive Compounds to Nucleotide Networks

  2025cites this paper
• Beneficial effects of resveratrol on diabetes mellitus and its complications: focus on mechanisms of action

  2024cites this paper
• Resveratrol delays the progression of diabetic nephropathy through multiple pathways: A dose–response meta‐analysis based on animal models

  2024cites this paper
• Targeting Autophagy: A Promising Therapeutic Strategy for Diabetes Mellitus and Diabetic Nephropathy

  2024cites this paper
• Effects of Phytochemicals on Type 2 Diabetes via MicroRNAs

  2024cites this paper
• Chinese botanical drugs targeting mitophagy to alleviate diabetic kidney disease, a comprehensive review

  2024cites this paper
• Potential role of resveratrol in prevention and therapy of diabetic complications: a critical review

  2024cites this paper
• Targeting autophagy with natural products as a potential therapeutic approach for diabetic microangiopathy

  2024cites this paper
• Protein phosphatase 2A modulation and connection with miRNAs and natural products

  2024cites this paper
• The regulatory role of miRNA and lncRNA on autophagy in diabetic nephropathy.

  2024cites this paper
• Melatonin reduces lung injury in type 1 diabetic mice by the modulation of autophagy

  2024cites this paper
• Shortcomings, limitations and gaps in physiological roles of extracellular vesicles in obesity.

  2024cites this paper
• Regulating miRNAs Expression by Resveratrol: Novel Insights based on Molecular Mechanism and Strategies for Cancer Therapy.

  2023cites this paper
• Effects of resveratrol on renal ischemia-reperfusion injury: A systematic review and meta-analysis

  2023cites this paper
• Melatonin alleviates renal injury in diabetic rats by regulating autophagy

  2023cites this paper
• Regulation of autophagy by natural polyphenols in the treatment of diabetic kidney disease: therapeutic potential and mechanism

  2023cites this paper
• Hydroxysafflor yellow A inhibits endothelial cell ferroptosis in diabetic atherosclerosis mice by regulating miR-429/SLC7A11

  2023influential citation
• Holistic expression of miR-17-92 cluster in obesity, kidney diseases, cardiovascular diseases, and diabetes

  2023cites this paper
• Regulation of autophagy by plant‐based polyphenols: A critical review of current advances in glucolipid metabolic diseases and food industry applications

  2023cites this paper
• An overview of natural products that modulate the expression of non-coding RNAs involved in oxidative stress and inflammation-associated disorders

  2023cites this paper
• Identification of biomarkers and prediction of upstream miRNAs in diabetic nephropathy

  2023cites this paper
• Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention

  2023cites this paper
• MicroRNA-365a/b-3p as a Potential Biomarker for Hypertrophic Scars

  2022cites this paper
• Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial.

  2022cites this paper
• The Role of the miR-17-92 Cluster in Autophagy and Atherosclerosis Supports Its Link to Lysosomal Storage Diseases

  2022cites this paper
• Polyphenols target miRNAs as a therapeutic strategy for diabetic complications

  2022cites this paper
• Diabetes and Cardiorenal Complications: A Clinical Review of Existing Therapies and Novel Combinations, Focusing on SGLT2 Inhibitors.

  2022cites this paper
• Long non-coding RNAs as emerging regulators of miRNAs and epigenetics in diabetes-related chronic kidney disease

  2022cites this paper
• Isorhapontigenin ameliorates high glucose-induced podocyte and vascular endothelial cell injuries via mitigating oxidative stress and autophagy through the AMPK/Nrf2 pathway

  2022cites this paper
• Disease-Associated Regulation of Non-Coding RNAs by Resveratrol: Molecular Insights and Therapeutic Applications

  2022cites this paper
• Antioxidant and Anti-inflammatory Properties of Resveratrol in Diabetic Nephropathy: A Systematic Review and Meta-analysis of Animal Studies

  2022influential citation
• Prospective Pharmacological Potential of Resveratrol in Delaying Kidney Aging

  2021cites this paper
• Dietary Polyphenols in Metabolic and Neurodegenerative Diseases: Molecular Targets in Autophagy and Biological Effects

  2021cites this paper
• Autophagy-regulating miRNAs: potential targets for obesity and related metabolic disorders.

  2021cites this paper
• An updated pharmacological insight of resveratrol in the treatment of diabetic nephropathy.

  2021cites this paper
• MicroRNAs, Parkinson’s Disease, and Diabetes Mellitus

  2021cites this paper
• LncRNA JPX regulates proliferation and apoptosis of nucleus pulposus cells by targeting the miR-18a-5p/HIF-1α/Hippo-YAP pathway.

  2021cites this paper
• Regulation of autophagy by miRNAs in human diseases

  2021cites this paper
• Plant Polyphenols for Aging Health: Implication from Their Autophagy Modulating Properties in Age-Associated Diseases

  2021cites this paper
• Role of microRNAs in Obesity-Related Kidney Disease

  2021cites this paper
• Therapeutic potential of resveratrol in diabetic nephropathy according to molecular signaling.

  2021cites this paper
• Histomorphometric evaluation of the rat kidney submitted to warm ischemia and the protective effect of resveratrol.

  2020cites this paper
• Dietary Polyphenols in Metabolic Diseases and Neurodegeneration: Molecular Targets on Autophagy and Biological Effects

  2020cites this paper
• Identifying Key MicroRNAs Targeted by Narenmandula in a Rodent Nephropathy Model

  2020cites this paper
• MicroRNA, Diabetes Mellitus and Colorectal Cancer

  2020cites this paper
• Resveratrol decreases high glucose-induced apoptosis in renal tubular cells via suppressing endoplasmic reticulum stress

  2020cites this paper
• Resveratrol inhibits hypertrophic scars formation by activating autophagy via the miR-4654/Rheb axis

  2020cites this paper
• Accelerated Kidney Aging in Diabetes Mellitus

  2020cites this paper
• Targeting miRNAs by natural products: A new way for cancer therapy.

  2020cites this paper
• Mechanisms of Herbal Nephroprotection in diabetes mellitus

  2020influential citation
• Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy

  2020cites this paper
• Resveratrol: Evidence for Its Nephroprotective Effect in Diabetic Nephropathy.

  2020cites this paper
• Resveratrol improves lipid metabolism in diabetic nephropathy rats.

  2020cites this paper
• Effects of a Red Orange and Lemon Extract in Obese Diabetic Zucker Rats: Role of Nicotinamide Adenine Dinucleotide Phosphate Oxidase

  2020cites this paper
• Therapeutic application of nutraceuticals in diabetic nephropathy: Current evidence and future implications

  2020cites this paper
• Methylglyoxal-induced miR-223 suppresses rat vascular KATP channel activity by downregulating Kir6.1 mRNA in carbonyl stress.

  2020cites this paper
• MicroRNAs: new biomarkers and promising therapeutic targets for diabetic kidney disease

  2019cites this paper
• Role of resveratrol in modulating microRNAs in human diseases: From cancer to inflammatory disorder.

  2019cites this paper
• Chinese Herbal Medicine in Ameliorating Diabetic Kidney Disease via Activating Autophagy

  2019influential citation
• Cocoa ameliorates renal injury in Zucker diabetic fatty rats by preventing oxidative stress, apoptosis and inactivation of autophagy.

  2019cites this paper
• Mechanisms of Action of Phenolic Phytochemicals in Diabetes Management

  2019cites this paper
• Oleanolic acid attenuated diabetic mesangial cell injury by activation of autophagy via miRNA-142-5p/PTEN signaling

  2019cites this paper
• MicroRNA: a novel biomarker and therapeutic target to combat autophagy in diabetic nephropathy.

  2019cites this paper
• LncRNA TCF7 triggered endoplasmic reticulum stress through a sponge action with miR-200c in patients with diabetic nephropathy.

  2019cites this paper
• MiR-92a contributes to the cardiovascular disease development in diabetes mellitus through NF-κB and downstream inflammatory pathways.

  2019cites this paper
• Resveratrol protects against oxidative damage of retinal pigment epithelium cells by modulating SOD/MDA activity and activating Bcl-2 expression.

  2019cites this paper
• Acute Kidney Injury and Progression of Diabetic Kidney Disease.

  2018cites this paper
• MiR-7 regulates the PI3K/AKT/VEGF pathway of retinal capillary endothelial cell and retinal pericytes in diabetic rat model through IRS-1 and inhibits cell proliferation.

  2018cites this paper
• Mitophagy Contributes to the Pathogenesis of Inflammatory Diseases

  2018cites this paper
• Study on the role of Hsa-miR-382-5p in epidural fibrosis.

  2018cites this paper
• Correlations between blood uric acid and the incidence and progression of type 2 diabetes nephropathy.

  2018cites this paper
• Microvesicles containing microRNA-21 secreted by proximal tubular epithelial cells are involved in renal interstitial fibrosis by activating AKT pathway.

  2018cites this paper